Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity
Victoria Lai, Sarah Y. Neshat, Amanda Rakoski, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113920-113920
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma
Zhongren Xu, Jianqiang Xu, Shibo Sun, et al.
Redox Biology (2022) Vol. 54, pp. 102351-102351
Open Access | Times Cited: 84
Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2023) Vol. 574, pp. 216397-216397
Open Access | Times Cited: 64
A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors
Ayuob Aghanejad, Samad Farashi Bonab, Maryam Sepehri, et al.
International Journal of Biological Macromolecules (2022) Vol. 207, pp. 592-610
Closed Access | Times Cited: 59
Tumor Acidic Microenvironment-Responsive Promodulator Iron Oxide Nanoparticles for Photothermal-Enhanced Chemodynamic Immunotherapy of Cancer
Siyu Chen, Yicheng Lv, Yue Wang, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 2, pp. 773-783
Closed Access | Times Cited: 21
Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence
Apoorv Kirti, Faizan Zarreen Simnani, Snehasmita Jena, et al.
Cancer Letters (2024) Vol. 594, pp. 216990-216990
Closed Access | Times Cited: 7
Visualized photodynamic nanomaterials activating tumor-associated immune landscape as a next-generation anticancer strategy
Luyao Tian, Xia Li, Lanping Guo, et al.
Coordination Chemistry Reviews (2024) Vol. 517, pp. 216027-216027
Closed Access | Times Cited: 7
Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity
Jinyan Wang, Hengyu Chen, Shu-Zhen Dai, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e003950-e003950
Open Access | Times Cited: 22
New Treatment Options in Metastatic Pancreatic Cancer
Marta Fudalej, Daria Kwaśniewska, Paweł Nurzyński, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2327-2327
Open Access | Times Cited: 9
Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments
Amir Fattahi, Mahboobeh Jafari, Ghazal Farahavar, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104437-104437
Closed Access | Times Cited: 3
Cardiac Injury Following Chemo/Radiation Therapy: An Updated Review on Mechanisms and Therapeutic Approaches
Krishanveer Singh, Ameer A. Alameri, Ammar Ali Hamza, et al.
Current Radiopharmaceuticals (2023) Vol. 16, Iss. 3, pp. 185-203
Closed Access | Times Cited: 9
Research Progress of circRNAs in Glioblastoma
Xu Guo, Haozhe Piao
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 19
A Smart “Energy NanoLock” Selectively Blocks Oral Cancer Energy Metabolism through Synergistic Inhibition of Exogenous Nutrient Supply and Endogenous Energy Production
Yurui Xu, Xiaomin Zhang, Anwei Zhou, et al.
Advanced Materials (2022) Vol. 35, Iss. 3
Closed Access | Times Cited: 14
Hydrogel-based approaches to target hypersensitivity mechanisms underlying autoimmune disease
Kenneth M. Kim, Arielle M. D’Elia, Christopher B. Rodell
Advanced Drug Delivery Reviews (2024) Vol. 212, pp. 115395-115395
Open Access | Times Cited: 2
Combinatorial regimens of chemotherapeutic agents: A new perspective on raising the heat of the tumor immune microenvironment
Jingyang Liu, Yang Yu, Cun Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Type-I Interferon Signaling Is Essential for Robust Metronomic Chemo-Immunogenic Tumor Regression in Murine Breast Cancer
Cameron Vergato, Kshama A. Doshi, Darren Roblyer, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 4, pp. 246-257
Open Access | Times Cited: 8
CCL14 exacerbates intraplaque vulnerability by promoting neovascularization in the human carotid plaque
Zhuo Li, Zhen Qin, Xiangyi Kong, et al.
Journal of Stroke and Cerebrovascular Diseases (2022) Vol. 31, Iss. 10, pp. 106670-106670
Closed Access | Times Cited: 8
Carbonic Anhydrase VIII (CAVIII) Gene Mediated Colorectal Cancer Growth and Angiogenesis through Mediated miRNA 16-5p
Mingli Hsieh, Pei‐Ju Huang, Pei-Yu Chou, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1030-1030
Open Access | Times Cited: 4
Research Progress with Luteolin as an Anti-Tumor Agent
Zhun Cai, Chenyang Mao, Yeqing Wang, et al.
Natural Product Communications (2022) Vol. 17, Iss. 11
Open Access | Times Cited: 3
Promotion of tumor angiogenesis and growth induced by low-dose antineoplastic agents via bone-marrow-derived cells in tumor tissues
Huining You, Peipei Zhao, Xue Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Antiangiogenic therapy exerts antitumor effects by altering the tumor microenvironment: bibliometric analysis
Yuan Yuan Kang, Yixin Kang, Dianbao Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Type-I interferon signaling is essential for robust metronomic chemo-immunogenic tumor regression in murine triple-negative breast cancer
Cameron Vergato, Kshama A. Doshi, Darren Roblyer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
The Expression of Angiogenesis Genes is Related to Immune Microenvironment and Prognosis of Lung Adenocarcinoma
Xue Wang, Xijian Liu, Lu Wang, et al.
Research Square (Research Square) (2023)
Open Access
PI3K inhibitor promotes tumor vessel normalization and improves treatment outcomes of breast cancer with doxorubicin
Baihui Li, Tian Yuan-yuan, Ju Huang, et al.
European Journal of Gynaecological Oncology (2023)
Open Access
Promotion of tumor angiogenesis and growth induced by low-dose antineoplastic agentsviabone-marrow-derived cells
Huining You, Peipei Zhao, Xue Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
The Expression of Angiogenesis Genes is Related to Immune Microenvironment and Prognosis of Lung Adenocarcinoma
Xue Wang, Xijian Liu, Wen‐Feng Zhang, et al.
(2023)
Open Access
Page 1 - Next Page

Scroll to top